SLC6A8 and neoplasm: Assessment of the TIME of LUAD in TCGA using the ESTIMATE algorithm also presented consistent results, with the SLC6A8 high-expression group showing significantly lower immune scores (Figure 4D) and stromal scores (Figure 4E) than the SLC6A8 low-expression group, while the tumor purity scores (Figure 4F) exhibited an opposite phenomenon.